Navigation Links
MEI Pharma Acquires PWT143, A Highly Selective PI3-Kinase Delta Inhibitor
Date:9/10/2013

ry and pre-clinical development of PWT143 to date," said Julie Cherrington, Ph.D., President and Chief Executive Officer of Pathway Therapeutics. "We continue to believe strongly in its potential to be an important drug for patients, and we are pleased that it is going into the hands of a team with the resources and drug development expertise to maximize that potential."

About MEI Pharma

MEI Pharma, Inc. (Nasdaq: MEIP) is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer. The Company's lead drug candidate is Pracinostat, a potential best-in-class, oral HDAC inhibitor being developed for advanced hematologic diseases, such as myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Results from a pilot Phase II clinical trial of Pracinostat in combination with Vidaza (azacitidine) in patients with MDS presented at the American Society of Hematology Annual Meeting in December 2012 showed an overall response rate of 89% (eight out of nine). In June 2013, the Company initiated a randomized, placebo-controlled Phase II trial of Pracinostat in combination with Vidaza in patients with previously untreated MDS. An open-label Phase II trial of Pracinostat in combination with Vidaza in elderly patients with AML unsuitable for induction therapy is expected to initiate in the fall of 2013. In addition, MEI Pharma is developing two drug candidates derived from its isoflavone-based technology platform, ME-143 and ME-344. Results from a first-in-human Phase I trial of ME-344 in patients with solid refractory tumors are anticipated in October 2013. For more information, go to www.meipharma.com.

Under U.S. law, a new drug cannot be marketed until it has been investigated in clinical trials and approved by the FDA as being safe a
'/>"/>

SOURCE MEI Pharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Boehringer Ingelheim Expands Investigation of Interferon-free Hepatitis C Treatment Regimens to Reach More Patient Types through Presidio Pharmaceuticals Clinical Collaboration
2. Roche and Inovio Pharmaceuticals partner on Inovios prostate cancer and hepatitis B immunotherapy products
3. UHC to Launch New Specialty Pharmacy Program for Better Continuity of Patient Care, Improved Access to Specialty Pharmaceuticals
4. Pharmaceutical Giants Back Researchers in Unique US Competition
5. Several Market Access Drivers Provide Attractive Opportunities for Multinational Companies in Saudi Arabias Pharmaceutical Market
6. DelMar Pharmaceuticals and Guangxi Wuzhou Pharmaceuticals Establish Clinical Advisory Board in China
7. Sunshine Act 2013 Updates: A Checklist for Pharmaceutical Companies to Meet CMS Reporting
8. PDL BioPharma Provides Third Quarter 2013 Revenue Guidance of $97 Million
9. Biogen Idec and Isis Pharmaceuticals Announce Strategic Collaboration to Advance Treatment of Neurological Disorders
10. Altaire Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of 9 lots of Carboxymethylcellulose Sodium 0.5% Ophthalmic Solution sold under several brands
11. SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Astex Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  In an unprecedented effort to curb the ... ambulances and other transport vehicles, an advanced and portable UV germicidal ... for the first time. In order to prevent ... deadly pathogens, West Palm Beach Fire Rescue ...
(Date:1/15/2014)... 2014  According to Millennium Research Group (MRG), the ... the United States and European ... expand moderately through 2022, with embolization particles representing ... interest in drug-eluting beads (DEBs) and radioembolization spheres ...
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that ... available in its catalogue: ... for Advanced Drug Delivery Systems -- ... http://www.reportlinker.com/p01941928/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-Routes-of-Administration.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ...
Breaking Medicine Technology:Superbugs No Longer Ride In Rescue Vehicles 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16
(Date:4/23/2014)... the depletion of self-control, according to research published in ... for Psychological Science. , Self-control can be difficult ... on a boring textbook are hard things to do. ... Exerting self-control for a long period seems to "deplete" ... , "It is as if self-control is a limited ...
(Date:4/22/2014)... industry leaders visited the New Jersey Institute of ... S. Bloom for the launch of the New ... provides a new model for business innovation through ... assets and investment. U.S. Senator Cory Booker, Panasonic ... Taylor, New Jersey Lieutenant Governor Kim Guadagno, New ...
(Date:4/22/2014)... at UT Southwestern Medical Center are making breakthroughs that ... A team of physician-scientists at UT Southwestern has ... with natural anti-depressant properties) works inside the brain. Simultaneously, ... depression in the form of a neuroprotective drug known ... in April,s issue of Molecular Psychiatry, is ...
(Date:4/22/2014)... Washington, DC (April 22, 2014) The International ... May 22-26 in Seattle, Washington. The theme of ... life" means in a networked and digital society. ... and attended by over 2,200 Communication scholars representing ... largest scholarly international communication conference in the world. ...
(Date:4/22/2014)... latest scientific advances and emerging therapies in heart failure ... annual meeting of the Heart Failure Association (HFA) of ... hear breaking news on acute heart failure during the ... part of the main congress. , The event will ... Megaron Athens International Conference Centre (MAICC). The full scientific ...
Breaking Medicine News(10 mins):Health News:ADHD drug may help preserve our self-control resources 2Health News:Government and industry leaders herald launch of NJIT's New Jersey Innovation Institute 2Health News:Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches 2Health News:Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches 3Health News:International Communication Association to hold Annual Conference in Seattle, Washington 2Health News:The world's largest heart failure congress 2Health News:The world's largest heart failure congress 3
... gender and weight, play role in infant,s chances, study ... When it comes to the survival of premature infants, ... gestational age, but a new study suggests that gestational ... and parents should consider when deciding what treatment, if ...
... -- Lotus,Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) (,Lotus, or ... China,("PRC"), today announced financial results for the fourth quarter ... Quarter 2007 Highlights -- Total revenues increased to ... quarter of 2006 -- Gross profit ...
... April 17 ProGenTech, a life,sciences company based ... to,announce that it has made several executive management ... Dr. Paul Richardson has joined ProGenTech as ... Dr. Richardson will lead the global R&D programs,and ...
... CRM Holdings,Ltd. ("the Company") (Nasdaq: CRMH ) ... wholly-owned subsidiary of the Company, has,received notice from ... following an initial investigation, the WCB has determined ... CRM,s third party,administrator,s license to provide third party ...
... 16 The California Nurses,Association,s (CNA) insistence on presenting ... the Service Employees International,Union (SEIU) reached new levels this ... admit photos it claimed as evidence of,"violence by protesters" ... images of SEIU staff and members injured by conference ...
... Consumer,Watchdog today joined L.A. City Attorney Rocky Delgadillo ... Blue Cross engaged in unfair,business practices by illegally ... sick., The practice -- known as "rescission" ... have been left uninsured, uninsurable, and facing up ...
Cached Medicine News:Health News:Gestational Age Not Sole Predictor of Preemie Survival 2Health News:Gestational Age Not Sole Predictor of Preemie Survival 3Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 2Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 3Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 4Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 5Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 6Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 7Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 8Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 9Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 10Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 11Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 12Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 13Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 14Health News:ProGenTech Limited Appoints Executive Management Team 2Health News:Compensation Risk Managers, LLC Receives Notice of Administrative Action by New York Workers' Compensation Board 2Health News:Compensation Risk Managers, LLC Receives Notice of Administrative Action by New York Workers' Compensation Board 3Health News:Consumer Watchdog Applauds L.A. City Attorney's Efforts to Reinstate Cancelled Blue Cross Patients; Urges State HMO Regulator to Immediately Reinstate Coverage 2
... solid made, manual plate washer for ... dispense and aspirate function ensure proper ... a stand and all necessary tubings. ... as well as any bottles for ...
... MP-1200 is a compact and simple ... internal micropumps enable the system both ... all types of microtiter well. MW-1200 ... in rows of 8 wells or ...
High precision microplate washer for immuno and adherent cell assays. For use with all strip types and full microplate in 96- and 384-well format in both portrait and landscape orientations....
The Wellwash 4 Mk 2 combines high performance and flexibility with reliability, simplicity and ease of use....
Medicine Products: